Company Search:
Advanced Search
Featured Products and Services

Wright Current Income Fund - 25th anniversary

Tissue Regenix Group PLC Company Snapshot
Tissue Regenix Group PLC operates within the Commercial physical research sector. In addition to historical fundamental analyses, the complete report available to purchase compares Tissue Regenix Group PLC with three other companies in this sector in the United Kingdom: Provexis PLC (2009 sales of £5,400.00 [US$9,030.10 ] ), Sareum Holdings PLC (£31,600.00 [US$52,842.78 ] of which 100% was Therapeutic Drugs), and Valirx Plc (£29,326.00 [US$49,040.11 ] of which 100% was Drug Development).

Sales Analysis.
  Stock Performance Chart for Tissue Regenix Group PLC
  Stock Data: Recent Stock Performance:
  Current Price (4/11/2014): 28.75p
(Figures in Pounds Sterling)
1 Week -3.4%   13 Weeks 0.9%  
4 Weeks 30.7%   52 Weeks 137.1%  
Tissue Regenix Group PLC Key Data:
  Ticker: TRX Country: United Kingdom
  Exchanges: LON Major Industry: Commercial Services & Supplies
    Sub Industry: Commercial Physical Research
  2009 Sales 18,000
(Year Ending Jan 2010).
Employees: 36
  Currency: Pounds Sterling Market Cap: 187,877,615
  Fiscal Yr Ends: January Shares Outstanding: 653,487,357
  Share Type: Ordinary Closely Held Shares: 461,201,955
Featured Products and Services
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.